Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers

Gut

Volumn 39, Issue 6, 1996, Pages 836-845

  Herfarth, H H ^a   Mohanty, S P ^a   Rath, H C ^a   Tonkonogy, S ^b   Sartor, R B ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

granuloma; inflammation; inflammatory bowel disease; interleukin 10

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; POLYMER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BACTERIAL CELL WALL; CELL FUNCTION; CROHN DISEASE; ENTEROCOLITIS; FEMALE; GENE EXPRESSION; GRANULOMATOUS INFLAMMATION; HEPATITIS; LEUKOCYTOSIS; LYMPH NODE; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0030480323     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.6.836     Document Type: Article

References (61)

1. Locksley RM. Th2 cells: Help for helminths. J Exp Med 1994; 179: 1405-7.
2. Herfarth HH, Sartor RB. Cytokine regulation of experimental intestinal inflammation. Current Opinion in Gastroenterology 1994; 10: 625-32.
3. Sartor RB. Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis. Inflammatory Bowel Disease 1995; 1: 64-75.
4. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin N Am 1995; 24: 475-507.
5. Sewell KL, Trentham DE. Pathogenesis of rheumatoid arthritis. Lancet 1993; 341: 283-6.
6. Atkinson MA, MacLaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-36.
7. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56: 1-16.
8. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993; 00: 713-39.
9. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149: 2496-505.
10. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24: 1434-40.
11. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74.
12. + T cells. Immunity 1994; 1: 553-62.
13. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, et al. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547-50.
14. Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108: 1917-22.
15. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995; 95: 2868-76.
16. Wahl SM, Hunt DA, Allen JB, Wilder RL, Paglia L, Hand AR. Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. J Exp Med 1986; 163: 884-902.
17. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994; 106: 960-72.
18. Cromartie WJ, Craddock JG, Schwab JH, Anderle SK, Yan CH. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977; 146: 1585-602.
19. Schwab JH. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun 1993; 61: 4535-9.
20. Sartor RB, Bender DE, Allen JB, Zimmermann EM, Holt LC, Pardo MS, et al. Chronic experimental enterocolitis and extraintestinal inflammation are T-lymphocyte dependent. Gastroenterology 1993; 104: 775A.
21. Allen JB, Malone DG, Wahl SM, Calandra GB, Wilder RL. Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J Clin Invest 1985; 76: 1042-56.
22. Yocum DE, Allen JB, Wahl SM, Calandra GB, Wilder RL. Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. Arthritis Rheum 1986; 29: 262-73.
23. Stimpson SA, Schwab JH. Chronic remittent erosive arthritis induced by bacterial peptidoglycan polysaccharide structures. In: Chang JY, Lewis AJ, eds. Pharmalogical methods in the control of inflammation. New York: Liss, 1989: 381-94.
24. Sartor RB, Cromartie WJ, Powell DW, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985; 89: 587-95.
25. Schwab JH, Anderle SK, Brown RR, Dalldorf FG, Thompson RC. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 1991; 59: 4436-42.
26. Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Meth Enzymol 1990; 186: 729-42.
27. Dijkema R, Van der Meide PH, Dubbeld M, Caspers MWJ, Schellekens H. Cloning, expression, and purification of rat IFN-gamma. Meth Enzymol 1986; 119: 453-63.
28. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC. Interleukin-1 receptor antagonist is a member of the interleukin-1 gene family: evolution of a cytokine control mechanism. Proc NatlAcad Sci USA 1991; 88: 5232-6.
29. Feeser W, Freimark BD. Nucleotide sequence of rat pro-interleukin-1 beta mRNA. GenBank 1992; Accession: M98820.
30. Kwon J, Chung I, Benveniste E. Cloning and sequence analysis of the rat tumor necrosis factor-encoding genes. Gene 1993; 132: 227-36.
31. Nishida T, Nishino N, Takano M, Sekiguchi Y, Kawai K, Mizuno KU, et al. Molecular cloning and expression of rat interleukin-1 alpha cDNA. J Biochem 1989; 105: 351-7.
32. Northemann W, Braciak TA, Hattori M, Lee F, Fey GH. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem 1989; 264: 16072-82.
33. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Vaffe D. The nucleotide sequence of the rat cytosplasmatic beta-actingene. Nucleic Acids Res 1983; 11: 1759-71.
34. Li L, Elliott JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 1994; 153: 3967-78.
35. Kossmann T, Manthey CL, Brandes ME, Morganti KMC, Ohura K, Allen JB, et al. Kupffer cells express type I TGF-beta receptors, migrate to TGF-beta and participate in streptococcal cell wall induced hepatic granuloma formation. Growth Factors 1992; 7: 73-83.
36. Manthey CL, Kossmann T, Allen JB, Corcoran ML, Brandes ME, Wahl SM. Role of Kupffer cells in developing streptococcal cell wall granulomas. Streptococcal cell wall induction of inflammatory cytokines and mediators. Am J Pathol 1992; 140: 1205-14.
37. Lichtman SN, Wang J, Schwab JH, Lemasters JJ. Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kupffer cells to produce tumor necrosis factor and interleukin-1. Hepatology 1994; 19: 1013-22.
38. Grewe M, Gausling R, Gyufko K, Hoffmann R, Decker K. Regulation of the mRNA expression for tumor necrosis factor-a in rat liver macrophages. J Hepatol 1994; 20: 811-8.
39. Schwab JH. Bacterial cell-wall induced arthritis: models of chronic recurrent polyarthritis and reactivation of monoarticular arthritis. In: Henderson B, Pettifer R, Edwards J, eds. Mechanisms and models in rheumatoid arthritis. London: Academic Press, 1995: 439-54.
40. Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol 1988; 140: 2964-9.
41. Brandes ME, Allen JB, Ogawa Y, Wahl SM. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991; 87: 1108-13.
42. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992; 267: 23301-8.
43. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-27.
44. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-9.
45. Paul WE. Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 1989; 57: 521-4.
46. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23: 2223-9.
47. Herfarth HH, Mohanty S, Rath HC, Sartor RB. In vivo IL-10 treatment suppresses chronic granulomatous inflammation and proinflammatory cytokine expression in experimental enterocolitis, arthritis and hepatitis. Gastroenterology 1996; 110: A924.
48. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-95.
49. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148: 3133-9
50. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-51.
51. Van Den Broeck MF, Van De Langerijt LG, Van Bruggen MC, Billingham ME, Van Den Berg WB. Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. Eur J Immunol 1992; 22: 57-61.
52. Pennline KJ, Roque GE, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169-75.
53. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994; 179: 1695-9.
54. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Comparison of suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 1995; 84: 536-42.
55. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154: 5492-9.
56. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434-44.
57. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 1995; 25: 1-5.
58. Neurath MF, Fuss I, Kelsall B, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182: 1281-90.
59. Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, et al. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994; 179: 1563-72.
60. Sartor RB. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Baltimore: Williams and Wilkins, 1995: 96-124.
61. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91: 8562-6.